The prescription of valproate: risk of harm

Lancet Neurol. 2024 Jun;23(6):557-558. doi: 10.1016/S1474-4422(24)00141-8.

Authors

Fergus Rugg-Gunn¹, David Hunt²

Affiliations

¹ Department of Clinical and Experimental Epilepsy, National Hospital for Neurology and Neurosurgery, Institute of Neurology, University College London, London, UK.
² Department of Clinical Neurosciences, NHS Lothian, Edinburgh EH16 4TJ, UK. Electronic address: david.hunt@ed.ac.uk.

PMID: 38760090
DOI: 10.1016/S1474-4422(24)00141-8

No abstract available

Publication types

Letter

MeSH terms

Anticonvulsants* / adverse effects
Anticonvulsants* / therapeutic use
Epilepsy / drug therapy
Humans
Valproic Acid* / adverse effects